Introduction to Acute Mechanical Circulatory Support

Similar documents
Acute Mechanical Circulatory Support Right Ventricular Support Devices

Case - Advanced HF and Shock (INTERMACS 1)

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Bridging With Percutaneous Devices: Tandem Heart and Impella

Percutaneous Mechanical Circulatory Support Devices

Assist Devices in STEMI- Intra-aortic Balloon Pump

Matching Patient and Pump in the New Era of Percutaneous Mechanical Circulatory Support

DECLARATION OF CONFLICT OF INTEREST

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4

The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities

The Robert TV Kung Interventional Heart Failure Fellowship Program Bringing Hope to the Hopeless at Tufts

Circulatory Support: From IABP to LVAD

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

Acute Myocardial Infarction Complicated by Cardiogenic Shock

Management of Acute Shock and Right Ventricular Failure

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research

Recovering Hearts. Saving Lives.

Cardiogenic Shock and Initiatives to Reduce Mortality

Mechanical circulatory support in cardiogenic shock The Cardiologist s view ACCA Masterclass 2017

Cath Lab Essentials : LV Assist Devices for Hemodynamic Support (IABP, Impella, Tandem Heart, ECMO)

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Andrew Civitello MD, FACC

Acute Circulatory Support Should We or Shouldn t We?

Cardiogenic Shock. Dr. JPS Henriques. Academic Medical Center University of Amsterdam The Netherlands

เอกราช อร ยะช ยพาณ ชย

Mechanics of Cath Lab Support Devices

Update on Mechanical Circulatory Support. AATS May 5, 2010 Toronto, ON Canada

Percutaneous Mechanical Circulatory Support for Cardiogenic Shock. 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist

Ted Feldman, M.D., MSCAI FACC FESC

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece

MANAGEMENT OF CARDIOGENIC SHOCK

The majority of patients with cardiomyopathy

Low cardiac output & Mechanical Support นายแพทย อรรถภ ม ส ศ ภอรรถ ศ ลยศาสตร ห วใจและทรวงอก โรงพยาบาล ราชว ถ

Mechanics of Cath Lab Support Devices

AllinaHealthSystem 1

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes

Percutaneous mechanical circulatory support for treatment and prevention of hemodynamic instability Engström, A.E.

Extra Corporeal Life Support for Acute Heart failure

Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know!

Understanding the Pediatric Ventricular Assist Device

The Role of Mechanical Circulatory Support in Cardiogenic Shock: When to Utilize

Acute heart failure: ECMO Cardiology & Vascular Medicine 2012

How to do Primary Angioplasty. - Patients with Cardiogenic Shock

ST-Elevation Myocardial Infarction & Cardiogenic Shock. - What Should We Do?

Surgical Options for Temporary MCS

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California

Ventricular Assisting Devices in the Cathlab. Unrestricted

Cardiogenic Shock in Acute MI

Ventricular Assist Devices for Permanent Therapy: Current Status and Future

A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD

Impella Versus Intra-Aortic Balloon Pump For Treatment Of Cardiogenic Shock: A Meta-Analysis of Randomized Controlled Trials

A National Cardiogenic Shock Initiative (CSI):

Who is the high risk patient?

New Horizons in Cardiogenic Shock. Timothy D. Henry, MD Director of Cardiology Cedars-Sinai Heart Institute

Cardiogenic Shock Protocol

1/5/2017. The Next Frontier: Advanced Cardiogenic Shock U MICHIGAN EPERIENCE

ECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan

ECMELLA. Associate Prof. Dirk Westermann, MD, PhD. Department of General and Interventional Cardiology Hamburg, Germany. Department of Medicine

Emergency surgery in acute coronary syndrome

Impella Ins & Outs. CarVasz November :45 12:15

The Case for Multivessel Revascularization in Shock

4/22/2016 Updated. AllinaHealthSystem. Cardiogenic Shock: Definition. No Disclosures. Cardiogenic Shock: Declining (But Still High) Case Fatality Rate

The number of patients in the United States with

TREATMENT OPTIONS IN CARDIOGENIC SHOCK WITH INTRA-AORTIC BALLOON COUNTERPULSATION

Echo assessment of patients with an ECMO device

Cardiogenic shock: Current management

Cardiogenic Shock. Carlos Cafri,, MD

MODULE 2 THE CLINICAL ENIGMA: RANDOMIZED TRIALS vs CLINICAL PRACTICE. Nico H. J. Pijls, MD, PhD Catharina Hospital Eindhoven The Netherlands

Total Artificial Hearts and Implantable Ventricular Assist Devices

ORIGINAL ARTICLE. Alexander M. Bernhardt a, *, Theo M.M.H. De By b, Hermann Reichenspurner a and Tobias Deuse a. Abstract INTRODUCTION

PUMP FAILURE COMPLICATING AMI: ISCHAEMIC VSR

Management of Cardiogenic shock. Prof. Christian JM Vrints

Definition. Low-cardiac-output state resulting in life threatening end-organ hypoperfusion. Criteria: MAP 30 mm Hg lower than baseline)

A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD

CABG for ischemic cardiomyopathy, post myocardial infarction and cardiogenic shock

Long-Term Management: Preventing Progression. Daniel Burkhoff Cardiovascular Research Foundation and Columbia University

CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock. Holger Thiele, MD on behalf of the CULPRIT-SHOCK Investigators

Why we need a consensus document on cardiogenic shock? ACCA Masterclass 2017

Number: Policy *Please see amendment for Pennsylvania Medicaid at the end. Last Review 03/23/2017 Effective: 03/25/2003 Next Review: 07/26/2018

LV Distension and ECLS Lungs

Advanced Care for Decompensated Heart Failure

Recovering Hearts. Saving Lives.

A Future for the IABP in Cardiogenic Shock? Holger Thiele Medical Clinic II (Cardiology/Angiology/Intensive Care) University of Lübeck, Germany

Innovative ECMO Configurations in Adults

Non Pharmacological Treatment of the Acute Heart Failure

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland

Planned, Short-Term RVAD During Durable LVAD Implant: Indications and Management

Ventricular Assist Devices (VADs) and Percutaneous Cardiac Support Systems

IABP SHOCK II trial:

Corrective Surgery in Severe Heart Failure. Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio

Outcomes for 15,259 US Patients With Acute MI Cardiogenic Shock (AMICS) Supported With Impella

Mitigating Operator Risk in Complex Interventional Procedures. Tanveer Rab, MD, FACC Ajay Kirtane, MD, FACC Prashant Kaul, MD, FACC

MEDICAL POLICY SUBJECT: VENTRICULAR ASSIST DEVICES

3/1/2017. Heart Failure is a major driver of morbidity and mortality in the US 1-7

Name of Policy: Ventricular Assist Devices and Total Artificial Hearts

ECMO as a Bridge to Heart Transplant in the Era of LVAD s.

206 Recent Developments in Intensive

Mechanical Cardiac Support and Cardiac Transplant: The Role for Echocardiography

Mechanical Circulatory Support in the Management of Heart Failure

Transcription:

Introduction to Acute Mechanical Circulatory Support Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced Heart Failure Programs Executive Director, The Cardiovascular Center for Research & Innovation

The Field of MCS: Robust with Innovation 2007 2017 IVADs HVAD Impella CP TH-RVAD CP TH + 5.0 Impella 5.0 RP BiPellas

Kirklin et al JHLT 2015 2007: A Major Inflection Point in CV Medicine HM-II BTT NEJM

No Definitive RCT Data Support Acute MCS Use for HR-PCI or Cardiogenic Shock Burkhoff : TH vs IABP Thiele : TH vs IABP (Cardiogenic Shock) Seyfarth: ISAR-SHOCK (Impella 2.5 vs IABP) Stretch and Bonde JACC 2014

Hemodynamic Efficacy Without Clear Clinical Benefit in Small RCTs Comparing Acute MCS Options Thiele and de Waha et al EHJ 2017

Less Use of IABP in Cardiogenic Shock Seyfarth: ISAR-SHOCK Burkhoff: TH vs IABP Thiele: TH vs IABP Patel : CRISP-AMI Thiele: IABP-SHOCK II JAMA 2015

Increasing Use of Continuous Flow in Cardiogenic Shock O Neill: PROTECT II (HR-PCI) O Neill: USPELLA AMI/Shock Kar: TandemHeart in CGS Seyfarth: ISAR-SHOCK (Impella 2.5 vs IABP) JAMA 2015

Clinical Success with Acute MCS: Less about the tools, More about how and when you use them Kapur and Davila Eur H J 2017

Indications for Acute Mechanical Circulatory Support High Risk Intervention 2014 AHA/ACC Guideline for the Management of Patients With Non ST- Elevation Acute Coronary Syndromes. Circulation Revascularization in Heart Failure: Class I Revascularization strategy based on degree, severity, & extent of CAD; cardiac lesions; extent of LV dysfunction; prior revascularization. PVADS: Large amount of ischemic territory/poor LV function 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. JACC High risk patients: Class IIb CLASS III: HARM without Hemodynamic support; for PCI at hospitals without onsite cardiac surgery Cardiogenic Shock* 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. JACC PCI and Cardiogenic Shock: Class I Use of Mechanical Circulatory Support: American Heart Association. Circulation 2012 Acutely decompensated heart failure patients: Class IIa 2013 Int l Society for Heart & Lung Transplantation Guidelines for Mechanical Circulatory Support. Jnl of Heart & Lung Transplantation Temporary mechanical support for patients with multiorgan failure: Class I 2013 ACCF/AHA Guideline for the Management of Heart Failure, JACC Bridge to Recovery or Bridge to Decision for acute, profound hemodynamic compromise: Class IIa 2013 ACCF/AHA Guideline for the Management of ST- Elevation Myocardial Infarction. Circulation STEMI and Cardiogenic Shock: Class IIb STEMI and urgent CABG: Class IIa *Impella is the only FDA-approved AMCS device for CGS

Pre-Session Question 1 Which of the following pumps employs a centrifugal flow rotary device? 1. Impella CP 2. Intra-aortic balloon pump 3. Veno-arterial extracorporeal membrane oxygenation 4. Heartmate Percutaneous Heart Pump (PHP)

Pre-Session Question 2 Which of the following 2 MCS devices reduce LV preload? 1. Impella CP 2. Intra-aortic balloon pump 3. Veno-arterial extracorporeal membrane oxygenation 4. TandemHeart left sided MCS device

Pre-Session Question 3 True or false. VA-ECMO can increase RV afterload? 1. True 2. False

Pre-Session Question 4 Which of the following devices can be used in the setting of acute aortic regurgitation? 1. Impella CP 2. Intra-aortic balloon pump 3. Veno-arterial extracorporeal membrane oxygenation 4. TandemHeart left sided MCS device

Pre-Session Question 5 Which of the following hemodynamic formulas has NOT been reported to identify severe RV failure in AMI? 1. Right atrial pressure 2. Right atrial:pulmonary capillary wedge pressure ratio 3. Pulmonary pulse pressure/right atrial pressure 4. Pulmonary artery compliance

Pre-Session Question 6 Which one of the following components of the LV pressure volume loop consume the most energy? 1. Isovolumic contraction 2. Isovolumic relaxation 3. Early diastolic filling 4. Systolic ejection

Pre-Session Question 7 Which one of the following is LEAST likely to improve North-South Syndrome with VA-ECMO? 1. Optimizing lung oxygenation and ventilation 2. VVA-ECMO 3. VAV-ECMO 4. VA-ECMO + Impella CP (ECPELLA)

Pre-Session Question 8 Which of the following configurations can be used for biventricular failure and shock in the setting of an LV thrombus? 1. Biventricular Impellas 2. VA-ECMO + Impella CP 3. VA-ECMO alone 4. VA-ECMO + LA venting